Insider Shareholders with Direct Ownership of Adaptimmune Therapeutics PLC (ADAP)
This section provides a comprehensive overview of the insiders with direct ownership of Adaptimmune Therapeutics PLC (ADAP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Adaptimmune Therapeutics PLC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Helen Katrina Tayton Martin
Chief Business & Strgy Officer |
1,785,000 | 0 | 1,800,000 $1.08 Million | 1 |
Mar 03, 2021
Added 49.79%
|
|
Gavin Wood
Chief Financial Officer |
63,000 | 0 | 96,000 $57,600 | 2 |
May 20, 2022
Added 28.89%
|
|
Garry E Menzel
Director |
209,931 | 47,702 | 75,056 $45,033 | 2 |
Jul 10, 2023
Reduced 38.86%
|
|
Adrian Rawcliffe
Chief Executive Officer |
0 | 182,520 | 44,848 $26,908 | 21 |
Jan 17, 2024
Reduced 40.15%
|
|
Cintia Piccina
Chief Commercial Officer |
0 | 57,461 | 38,293 $22,975 | 3 |
Jun 18, 2024
Reduced 39.05%
|
|
William C Bertrand Jr
Chief Operating Officer |
207,000 | 73,642 | 20,201 $12,120 | 16 |
Jan 17, 2024
Reduced 40.23%
|
|
Elliot Norry
Chief Medical Officer |
0 | 58,089 | 19,257 $11,554 | 15 |
Jan 17, 2024
Reduced 40.24%
|
|
John Lunger
Chief Patient Supply Officer |
0 | 76,043 | 19,015 $11,409 | 20 |
Jan 17, 2024
Reduced 40.24%
|